Global Sterile Injectable Market Trends, Analysis, Growth, and Forecast: 2018 to 2027
-
2784
-
May 2023
-
153
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
Sterile Injectable Market Overview
"The Sterile Injectable Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031."
The sterile injectable molecule used as active substances is divided into two classes, large and small molecules,s as they differ in size, manufacturing process, and mode of action in the body. Small molecules are chemically manufactured active-substance molecules, whereas large molecules, also known as biologics, are therapeutic proteins composed of more than 1,300 amino acids. In addition, the large molecule is produced via genetically modified cells of microorganisms such as yeast and bacteria.
Increasing investment in R &D by major market players for developing disease-specific drugs is expected to contribute to the growth of the global sterile injectable market. In addition, increasing the prevalence of chronic diseases such as diabetes and cardiovascular disease will contribute to the growth of the global sterile injectable market. Furthermore, the increasing number of drug approvals by the health authorities for injectable and subsequently successful launching and commercialization of innovative drugs is anticipated to drive further the growth of the global sterile injectable market over the forecast period.
A major factor restraining the growth of the global sterile injectable market is the manufacturing of sterile injectables' high cost of equipment, packaging, storage, and distribution.
However, a company focusing on developing innovative drugs that can absorb into the body quickly and provide a quick therapeutic response will create new opportunities for major players in the global sterile injectable market over the forecast period.
North American market dominates the global sterile injectable market in terms of revenue contribution as compared to that of markets in other regions. in the region. Europe accounts for the second-largest revenue share contribution to the global sterile injectable market, followed by markets in Latin America, Asia Pacific, and the Middle East & Africa, respectively. The market in the Asia Pacific is projected to register comparatively faster growth in revenue over the next 10 years, owing to increasing investment by key market players in emerging markets and an increase in the prevalence of chronic diseases in the region.
Global Sterile Injectable Market Segmentation:
Global sterile injectable market segmentation by type:
- Small Molecule
- Large Molecule
Global sterile injectable market segmentation by therapeutic application:
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems
- Infectious Disorders
- Musculoskeletal
- Anti-Viral
- Others
Global sterile injectable market segmentation by distribution channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
 Global sterile injectable market segmentation by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
-
- AstraZeneca plc.
- Baxter International Inc.
- Johnson & Johnson
- Novartis AG
- Merck & Co., Inc.
- Sanofi S.A.
- Pfizer Inc.
- GlaxoSmithKline plc.
- Gilead Sciences, Inc.
- Nova Nordisk A/S
Our Clients
View Our Licence Options
